Literature DB >> 11939733

The molecular characterization of fatal infectious mononucleosis.

Myra J Wick1, Kristine P Woronzoff-Dashkoff, Ronald C McGlennen.   

Abstract

We describe a retrospective study of 4 cases of sporadic fatal infectious mononucleosis (IM), 1 case of fatal IM, and 1 case of sporadic severe IM. Patients were 26 months to 17 years old; 3 were male. Five died of complications of IM. All 5 of these patients had the Epstein-Barr virus (EBV) present in examined tissue specimens; EBV was monoclonal in 3 patients and biclonal in 1. EBV clonality studies were not performed in the remaining patient. All 5 patients also had monoclonal gene rearrangements. The sixth patient survived despite a life-threatening clinical course; EBV was oligoclonal, and gene rearrangements were not detected. EBV clonality and gene rearrangement studies may be usefulfor predicting which patients with clinically aggressive IM are at highest risk for fatal outcome. Patients in whom IM has a fatal outcome are more likely to have monoclonal or biclonal EBV and immunoglobulin heavy chain or T-cell receptor gene rearrangements. In contrast, patients with nonfatal IM may lack monoclonal EBV and monoclonal rearrangements of the aforementioned genes. The reasons EBV induces a monoclonal proliferation only in some patients remain to be elucidated.

Entities:  

Mesh:

Year:  2002        PMID: 11939733     DOI: 10.1309/b3wh-qwby-yv61-ce46

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

Review 1.  Selected topics on lymphoid lesions in the head and neck regions.

Authors:  Wesley O Greaves; Sa A Wang
Journal:  Head Neck Pathol       Date:  2011-02-03

2.  T-cell receptor gene rearrangement in Epstein-Barr virus infectious mononucleosis.

Authors:  L Marbello; M Riva; S Veronese; A M Nosari; E Ravano; A Colosimo; L Paris; E Morra
Journal:  Med Oncol       Date:  2011-05-24       Impact factor: 3.064

Review 3.  The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Authors:  Megan C Smith; Daniel N Cohen; Bruce Greig; Ashwini Yenamandra; Cindy Vnencak-Jones; Mary Ann Thompson; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.

Authors:  Obinna Chijioke; Anne Müller; Regina Feederle; Mario Henrique M Barros; Carsten Krieg; Vanessa Emmel; Emanuela Marcenaro; Carol S Leung; Olga Antsiferova; Vanessa Landtwing; Walter Bossart; Alessandro Moretta; Rocio Hassan; Onur Boyman; Gerald Niedobitek; Henri-Jacques Delecluse; Riccarda Capaul; Christian Münz
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

5.  Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature.

Authors:  Valentina Tabanelli; Claudio Agostinelli; Elena Sabattini; Anna Gazzola; Francesco Bacci; Saveria Capria; Claudia Mannu; Simona Righi; Maria Teresa Sista; Giovanna Meloni; Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Med Case Rep       Date:  2011-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.